Summary: H.R.2069 — 116th Congress (2019-2020)All Information (Except Text)

There is one summary for H.R.2069. Bill summaries are authored by CRS.

Shown Here:
Introduced in House (04/03/2019)

Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.